Sierra Oncology, Inc.

NasdaqGM:SRRA Stock Report

Market Cap: US$1.3b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Sierra Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SRRA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders21,0300.0861%
Public Companies725,2832.97%
Hedge Funds1,266,9275.19%
VC/PE Firms2,342,1989.59%
General Public8,422,88434.5%
Institutions11,641,02747.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 97.7%.


Top Shareholders

Top 25 shareholders own 57.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.59%
Frazier Life Sciences Management, LP
2,342,198US$128.8m0%11.89%
5.19%
Towers Watson Investment Management (Ireland) Limited
1,266,927US$69.7m0%63.53%
4.81%
Rock Springs Capital Management LP
1,174,786US$64.6m-0.84%1.95%
4.35%
PFM Health Sciences, LP
1,062,888US$58.4m0%2.65%
4.1%
Adage Capital Management, L.P.
1,000,000US$55.0m-18.7%0.12%
3.16%
Paradigm Biocapital Advisors LP
771,314US$42.4m62.4%12.32%
2.97%
Gilead Sciences, Inc.
725,283US$39.9m0%no data
2.34%
Sofinnova Investment, Inc.
572,297US$31.5m170%2.81%
1.92%
Citadel Advisors LLC
467,809US$25.7m0%0.04%
1.84%
BlackRock, Inc.
448,430US$24.7m1,810%no data
1.82%
Silverarc Capital Management, LLC
443,381US$24.4m131%12.19%
1.81%
Goldman Sachs Group, Investment Banking and Securities Investments
441,005US$24.3m0%0.02%
1.74%
Laurion Capital Management LP
425,000US$23.4m0%0.72%
1.53%
The Vanguard Group, Inc.
372,849US$20.5m35.4%no data
1.33%
Ghost Tree Capital, LLC
325,000US$17.9m30%10.04%
1.23%
Tang Capital Management, LLC
300,000US$16.5m0%3.23%
1.23%
Two Sigma Investments, LP
299,960US$16.5m471%0.06%
1.17%
Marshall Wace LLP
284,781US$15.7m0%0.05%
1.05%
Two Sigma Advisers, LP
256,556US$14.1m315%0.05%
0.89%
Ikarian Capital, LLC
217,915US$12.0m-61.7%4.48%
0.79%
Kynam Capital Management, LP
193,280US$10.6m0%3.92%
0.68%
J. Goldman & Co., L.P.
166,550US$9.2m0%0.8%
0.67%
VR Adviser, LLC
162,479US$8.9m0%1.02%
0.62%
Parkman Healthcare Partners LLC
151,915US$8.4m0%2.96%
0.56%
EAM Investors, LLC
136,692US$7.5m0%1.67%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.